We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Eli Lilly and Co | NYSE:LLY | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 2.05 | 0.26% | 778.80 | 12,373 | 14:26:45 |
From May 2019 to May 2024
By Josh Beckerman
The initial public offering of Elanco Animal Health Inc. (ELAN), a unit of Eli Lilly & Co. (LLY), priced above its expected range on Wednesday.
The 62.9 million-share IPO priced at $24, compared with the projected range of $20 to $23.
Elanco reported revenue of $2.89 billion in 2017, with a pro forma net loss of $378.9 million.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
September 19, 2018 17:37 ET (21:37 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Eli Lilly Chart |
1 Month Eli Lilly Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
